Fig. 2 | npj Vaccines

Fig. 2

From: A recombinant vesicular stomatitis-based Lassa fever vaccine elicits rapid and long-term protection from lethal Lassa virus infection in guinea pigs

Fig. 2

Viral burden and serological analysis of rapid vaccination with VSVΔG-LASVGPC. TCID50 analysis of serum, liver, lung and spleen collected from animals vaccinated a 7/14 DPV (2-Way Anova; Dunnett’s) and b 25 DPV (T-test; Holm-Sidak). Total LASVGPC-specific IgG titers were assessed by endpoint titration and the Log ECF90 for each time-point calculated for animals challenged c 7/14 DPV (One-Way Anova; Dunnett’s) and d 25 DPV (Two-tailed T-test), respectively. Data are presented as mean values with error bars indicating SEM. p = 0.1234 (ns), 0.0332 (*), 0.0021 (**), 0.0002 (***), <0.0001 (****)

Back to article page